Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaofeng Dou

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2021
High-resolution pediatric age-specific <sup>18</sup>F-FDG PET template: a pilot study in epileptogenic focus localizationTeng Zhang, Yuting Li, Shuilin Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 30, 2025
Diagnostic performance of deep learning-assisted [<sup>18</sup>F]FDG PET imaging for Alzheimer's disease: a systematic review and meta-analysisYuan Sun, Yuhan Chen, La Dong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2025
Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural BasisBo Wang, Haotian Wang, Yixin Kang, et al.
Neurology|February 11, 2026
Brain Network Patterns in Patients With Multiple System Atrophy: Spatial Independent Component Analysis Using FDG-PET DataHaotian Wang, Bo Wang, Yi Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2024
Identification of metabolic progression and subtypes in progressive supranuclear palsy by PET molecular imagingHaotian Wang, Bo Wang, Yi Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2026
Baseline amyloid deposition phenotypes inform the spatial distribution of early amyloid clearance with lecanemab in Alzheimer's diseaseXiaofeng Dou, Daoyan Hu, Jing Wang, et al.
Anti-Cancer Drugs|March 4, 2014
A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathwayFanwei Zeng, Fanghong Luo, Sha Lv, et al.
Journal of Movement Disorders|September 25, 2023
Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear PalsyYueting Chen, Haotian Wang, Bo Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 3, 2022
International consensus on the use of tau PET imaging agent <sup>18</sup>F-flortaucipir in Alzheimer's diseaseMei Tian, A Cahid Civelek, Ignasi Carrio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2023
International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonismMei Tian, Chuantao Zuo, A Cahid Civelek, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2021
High-resolution pediatric age-specific <sup>18</sup>F-FDG PET template: a pilot study in epileptogenic focus localizationTeng Zhang, Yuting Li, Shuilin Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 30, 2025
Diagnostic performance of deep learning-assisted [<sup>18</sup>F]FDG PET imaging for Alzheimer's disease: a systematic review and meta-analysisYuan Sun, Yuhan Chen, La Dong, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 30, 2025
Spatial Metabolic Covariance Networks in Progressive Supranuclear Palsy: Implications for Symptomatology and Their Neural BasisBo Wang, Haotian Wang, Yixin Kang, et al.
Neurology|February 11, 2026
Brain Network Patterns in Patients With Multiple System Atrophy: Spatial Independent Component Analysis Using FDG-PET DataHaotian Wang, Bo Wang, Yi Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2024
Identification of metabolic progression and subtypes in progressive supranuclear palsy by PET molecular imagingHaotian Wang, Bo Wang, Yi Liao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 15, 2026
Baseline amyloid deposition phenotypes inform the spatial distribution of early amyloid clearance with lecanemab in Alzheimer's diseaseXiaofeng Dou, Daoyan Hu, Jing Wang, et al.
Anti-Cancer Drugs|March 4, 2014
A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathwayFanwei Zeng, Fanghong Luo, Sha Lv, et al.
Journal of Movement Disorders|September 25, 2023
Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear PalsyYueting Chen, Haotian Wang, Bo Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 3, 2022
International consensus on the use of tau PET imaging agent <sup>18</sup>F-flortaucipir in Alzheimer's diseaseMei Tian, A Cahid Civelek, Ignasi Carrio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2023
International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonismMei Tian, Chuantao Zuo, A Cahid Civelek, et al.
Pageof 5